The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial - Immunity & Ageing

  • 📰 BioMedCentral
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 71%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

A study published in Immunity & Ageing discusses the potential utility of metformin to improve flu vaccine responses and immunological resilience in nondiabetic older adults. Further investigation with a larger sample size is required.

]. Combined with this, our study suggests that metformin may have additional utility for improvements in immunological resilience and vaccination responses in nondiabetic and nonprediabetic older adults. It is also possible that metformin may have more prominent immune benefits in older adults who are prediabetic, prefrail, frail, or have other comorbidities that were excluded from this pilot trial.

The study protocol was approved by the Institutional Review Board at the University of Connecticut Health Center and registered at ClinicalTrials.gov . All study participants provided written informed consent to participate in the study. Subjects were screened for eligibility, and if eligible, were randomized to metformin /day) or placebo.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 22. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Acupuncture for post-stroke depression: a systematic review and network meta-analysis - BMC PsychiatryBackground Patients with post-stroke depression (PSD) usually experience anxiety, hopelessness, and insomnia, which have a negative impact on their daily activities and post-stroke rehabilitation. Acupuncture (AC), as a minimally invasive technique, has become a popular choice for improving depression symptoms. However, it is still unclear which therapy is associated with the best outcomes for PSD. In this review, we aimed to explore the impact of AC in alleviating symptoms of PSD and to evaluate the difference in effectiveness between AC combined with pharmacotherapies and various non-pharmacotherapies. Methods Six databases and three clinical trials registration platforms were searched from inception to March 2023. Randomized clinical trial comparing needle-based AC with pharmacotherapy, and other non-pharmacotherapy or invalid group were included. Two independent reviewers identified eligible studies, and collected data using a pre-made form. A Bayesian network meta-analysis was conducted to assess and compare different techniques using RStudio 3.6.0 with the package ‘GEMTC’ V.0.8.1. The primary outcome was the efficacy for PSD assessed by scales measuring depressive symptoms. The secondary outcomes were effectiveness for neurological function and the quality of life. The ranking probabilities for all treatment interventions was performed using the Surface Under the Cumulative Ranking curve (SUCRA). The risk of bias was assessed by using the Revised Cochrane Risk of Bias tool 2. Results Sixty-two studies, involving 5308 participants published from 2003 to 2022, were included. The results showed that compared with western medicine (WM) (defined as pharmacotherapy for PSD), AC alone or with repetitive transcranial magnetic stimulation (RTMS), Traditional Chinese medicine (TCM) alone or with WM, were superior for alleviating depression symptoms. Compared to Usual Care, AC alone or plus other therapies could significantly decrease scores on the Hamilton Depression Ra
Source: BioMedCentral - 🏆 22. / 71 Read more »